Inovio Pharmaceuticals, Inc.

San Diego, CA

UEI
CE2NDNHN33X5
CAGE
43MD0
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
Corporate family
SAM.gov registration date
Physical address
6769 Mesa Ridge Rd, San Diego, CA 92121, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
"covid-19" prototype development of an electroporation device. W911QY2090016 ACC Aberdeen Proving Ground $54,472,799
Cellectra 2000 array W911QY20C0084 ACC Aberdeen Proving Ground $10,664,397
Sbir phase i army 2010.3 log # 11343003 W81XWH11C0051 Medical Command (Army) $1,334,679

Grant awards

Award Agency Obligated Awarded
Grant with inovio pharmaceuticals, INC. For proposal entitled, "immediate and persistent protection against ebola zaire" W31P4Q1510003 Department of Defense $44,160,180
Design and engineering of the elgen gene delivery system for screening and validation of vaccine candidates of military… W81XWH0820200 Department of Defense $932,450

Grant subawards

Prime recipient Prime award Amount Awarded
The Wistar Institute Of Anatomy And Biology Dr. Smith will serve as a program director in the administrative core for the IPCAVD program and PI for Project 3, and will assist the NHP steering committee,… U19AI166916 $5,554,534
The Wistar Institute Of Anatomy And Biology Dr. Smith will serve as a program director in the administrative core for the IPCAVD program and PI for Project3, and will assist the NHP steering committee,… U19AI166916 $2,249,957

Similar vendors

Vendor Location Primary NAICS
Bavarian Nordic A / S UEI D2WABKK2LYX4 Hellerup 325414 Biological Product (except Diagnostic) Manufacturing
Medigen, Inc. UEI MGLJHKGKWBL3 Frederick, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Corporate UEI ZXHWXURNS6W8 Gaithersburg, MD 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Tendel Therapies Inc. UEI JA9BDUH73852 Kensington, CA 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Aldevron, L.l.c UEI GM49EPBCC4R7 Fargo, ND 325414 Biological Product (except Diagnostic) Manufacturing

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Inovio Pharmaceuticals, Inc. is a for-profit corporation that provides medical and pharmaceutical research and development services to U.S. federal agencies. The company focuses on developing DNA vaccines and immunotherapies that treat and prevent diseases.

Inovio has received two recent prime federal contracts from the Department of Defense to support development of medical countermeasures against biological threats like COVID-19. The contracts, totaling over $65 million, fund Inovio's efforts to develop a DNA vaccine delivery device and associated arrays. The contracts utilize firm fixed pricing and other transaction agreement mechanisms. No set-aside designations or subcontractors were specified.

Inovio has also received three recent federal grant subawards to conduct preclinical research and development related to HIV and other vaccines. As a subawardee to the prime grantee Wistar Institute, Inovio provides program direction, project management, DNA vaccine development, and manufacturing services. The subawards support the larger goals of the prime awards in facilitating communications and coordination between project partners and delivering program updates to the National Institutes of Health.

Quick answers

Is Inovio Pharmaceuticals, Inc. registered in SAM.gov?

Yes. Inovio Pharmaceuticals, Inc.'s SAM.gov registration is active through January 13, 2027.

What is Inovio Pharmaceuticals, Inc.'s most recent federal award?

Inovio Pharmaceuticals, Inc.'s most recent federal contract award is "covid-19" prototype development of an electroporation device (W911QY2090016), from ACC Aberdeen Proving Ground, on June 22, 2020.

On GovTribe

See Inovio Pharmaceuticals, Inc.'s full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login